Jeffrey S. Glenn founded Eiger BioPharmaceuticals, Inc. and Eiger BioPharmaceuticals, Inc.

He is on the board of Eiger BioPharmaceuticals, Inc. and Member of American Society for Clinical Investigation and Associate Professor & Director-Hepatitis Center at Stanford University School of Medicine.

He previously occupied the position of Director at Eiger BioPharmaceuticals, Inc.

Dr. Glenn received an undergraduate degree from the University of California, Berkeley and a doctorate from The University of California, San Francisco.